Medicamen Biotech has informed that it enclosed a certificate dated April 12, 2022 obtained from AMJ & Associates, Practicing Company Secretaries for the year ended March 31, 2022, pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.